Houyuan Chen, Chong Shen, Yunkai Qie, Yuda Lin, Qinliang Si, Zhouliang Wu, Shaobo Yang, Kaipeng Jia, Zihan Xue, Ning Kang, Hailong Hu. "Neoadjuvant tislelizumab in combination with disitamab vedotin (RC48) followed by distal ureterectomy for patients with HER-2 expressing lower segment ureteral carcinoma (LSUC): A single-arm, phase II, single-center study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.765